European medical technology takes steps to create an environment for a thriving industry
This article was originally published in Clinica
Technological progress in the medtech sector is best facilitated by an appropriate regulatory system, adequate funding of innovative R&D and companies receiving payments for products within reasonable time limits. Eucomed director-general Maurice Wagner expanded on these and other pressing themes in an exclusive interview with Amanda Maxwell at the association's impressive new offices in Brussels
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.